Nature Communications (Apr 2023)

Delayed generation of functional virus-specific circulating T follicular helper cells correlates with severe COVID-19

  • Meng Yu,
  • Afandi Charles,
  • Alberto Cagigi,
  • Wanda Christ,
  • Björn Österberg,
  • Sara Falck-Jones,
  • Lida Azizmohammadi,
  • Eric Åhlberg,
  • Ryan Falck-Jones,
  • Julia Svensson,
  • Mu Nie,
  • Anna Warnqvist,
  • Fredrika Hellgren,
  • Klara Lenart,
  • Rodrigo Arcoverde Cerveira,
  • Sebastian Ols,
  • Gustaf Lindgren,
  • Ang Lin,
  • Holden Maecker,
  • Max Bell,
  • Niclas Johansson,
  • Jan Albert,
  • Christopher Sundling,
  • Paulo Czarnewski,
  • Jonas Klingström,
  • Anna Färnert,
  • Karin Loré,
  • Anna Smed-Sörensen

DOI
https://doi.org/10.1038/s41467-023-37835-9
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 14

Abstract

Read online

Abstract Effective humoral immune responses require well-orchestrated B and T follicular helper (Tfh) cell interactions. Whether these interactions are impaired and associated with COVID-19 disease severity is unclear. Here, longitudinal blood samples across COVID-19 disease severity are analysed. We find that during acute infection SARS-CoV-2-specific circulating Tfh (cTfh) cells expand with disease severity. SARS-CoV-2-specific cTfh cell frequencies correlate with plasmablast frequencies and SARS-CoV-2 antibody titers, avidity and neutralization. Furthermore, cTfh cells but not other memory CD4 T cells, from severe patients better induce plasmablast differentiation and antibody production compared to cTfh cells from mild patients. However, virus-specific cTfh cell development is delayed in patients that display or later develop severe disease compared to those with mild disease, which correlates with delayed induction of high-avidity neutralizing antibodies. Our study suggests that impaired generation of functional virus-specific cTfh cells delays high-quality antibody production at an early stage, potentially enabling progression to severe disease.